GEMTESA is the first and only beta-3 agonist approved for the treatment of men with OAB symptoms who are receiving pharmacological therapy for BPH
This approval is a significant achievement in expanding the availability of this critical therapeutic,
JCI accreditation is recognized globally
The company will receive an upfront payment of Euro 100 million (Rs. 880 crores) for product development and site approval from European authorities
This facility is considered to be in a minimally acceptable state of compliance with regard to current GMP
The technical program will run in four sessions and a panel discussion on “Challenges in translation of medical technologies”
This curated geriatric care package - Varishtha Aarogya Vardaan -- includes a comprehensive range of essential blood tests specifically curated for seniors.
Pflow is a revolutionary, disposable, and portable home based urine flow measurement test
The transaction is expected to result in approximately $175 million to support further development of IMG-007
Divestment is part of BASF’s strategic portfolio optimization
Subscribe To Our Newsletter & Stay Updated
